- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Reduced contrast CT lowers cost, risk in elderly patients
Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality.
Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality. A lower dose could also reduce costs and the risk of complications.
Dr. Shigeki Itoh, a radiologist at Nagoya University School of Health Science in Japan, and colleagues assessed 112 patients who had undergone triple-phase contrast-enhanced CT exams on a 16-slice scanner for known or suspected pancreatobiliary disease. They split the patients into three groups according to age and weight (AJR 2006 Aug;187[2]:505-510).
The investigators found that after a 12.2% reduction in the volume and rate of contrast injection, they could achieve equivalent contrast enhancement in patients older than 60 as compared with patients aged 60 or younger undergoing scanning with a standard dose.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
